- Home
- BHF vs OGN Comparison
BHF vs OGN Comparison
Compare BHF & OGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BHF
- OGN
- Stock Information
- Founded
- BHF 2016
- OGN 1923
- Country
- BHF United States
- OGN United States
- Employees
- BHF N/A
- OGN N/A
- Industry
- BHF Life Insurance
- OGN Biotechnology: Pharmaceutical Preparations
- Sector
- BHF Finance
- OGN Health Care
- Exchange
- BHF Nasdaq
- OGN Nasdaq
- Market Cap
- BHF 2.8B
- OGN 2.5B
- IPO Year
- BHF N/A
- OGN N/A
- Fundamental
- Price
- BHF $50.21
- OGN $10.21
- Analyst Decision
- BHF Hold
- OGN Hold
- Analyst Count
- BHF 10
- OGN 4
- Target Price
- BHF $57.40
- OGN $18.00
- AVG Volume (30 Days)
- BHF 911.2K
- OGN 3.6M
- Earning Date
- BHF 08-07-2025
- OGN 08-05-2025
- Dividend Yield
- BHF N/A
- OGN 0.78%
- EPS Growth
- BHF N/A
- OGN N/A
- EPS
- BHF 8.45
- OGN 2.88
- Revenue
- BHF $8,610,000,000.00
- OGN $6,294,000,000.00
- Revenue This Year
- BHF $41.64
- OGN N/A
- Revenue Next Year
- BHF $2.59
- OGN $1.11
- P/E Ratio
- BHF $5.87
- OGN $3.54
- Revenue Growth
- BHF 165.09
- OGN N/A
- 52 Week Low
- BHF $40.00
- OGN $8.01
- 52 Week High
- BHF $64.12
- OGN $23.10
- Technical
- Relative Strength Index (RSI)
- BHF 42.09
- OGN 58.77
- Support Level
- BHF $48.55
- OGN $9.55
- Resistance Level
- BHF $51.07
- OGN $10.22
- Average True Range (ATR)
- BHF 1.57
- OGN 0.30
- MACD
- BHF 0.17
- OGN 0.04
- Stochastic Oscillator
- BHF 53.26
- OGN 93.64
About BHF Brighthouse Financial Inc.
Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.
About OGN Organon & Co.
Organon & Co is a science-based pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. The Company's operations include the following product portfolio: Women's health, Biosimilars and Established medicines. Geographically, it derives a majority of its revenue from Europe and Canada followed by the United States and then Asia Pacific and Japan. The company generates the majority of its revenue from the Established Brands product portfolio.